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Abstract The islets of Langerhans contain different types of
endocrine cells, which are crucial for glucose homeostasis. β-
and α-cells that release insulin and glucagon, respectively, are
most abundant, whereas somatostatin-producing δ-cells and
particularly pancreatic polypeptide-releasing PP-cells are
more scarce. Studies of islet cell function are hampered by
difficulties to identify the different cell types, especially in
live-cell imaging experiments when immunostaining is un-
suitable. The aim of the present study was to create a set of
vectors for fluorescent protein expression with cell-type-
specific promoters and evaluate their applicability in function-
al islet imaging. We constructed six adenoviral vectors for
expression of red and green fluorescent proteins controlled
by the insulin, preproglucagon, somatostatin, or pancreatic
polypeptide promoters. After transduction of mouse and hu-
man islets or dispersed islet cells, a majority of the fluorescent
cells also immunostained for the appropriate hormone.
Recordings of the sub-plasma membrane Ca2+ and cAMP
concentrations with a fluorescent indicator and a protein bio-
sensor, respectively, showed that labeled cells respond to glu-
cose and other modulators of secretion and revealed a striking
variability in Ca2+ signaling among α-cells. The measure-
ments allowed comparison of the phase relationship of Ca2+
oscillations between different types of cells within intact islets.
We conclude that the fluorescent protein vectors allow easy
identification of specific islet cell types and can be used in
live-cell imaging together with organic dyes and genetically
encoded biosensors. This approach will facilitate studies of
normal islet physiology and help to clarify molecular defects
and disturbed cell interactions in diabetic islets.
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Introduction
The pancreatic islets of Langerhans are key regulators of glucose
homeostasis. They contain four major types of endocrine cells:
α-,β-,δ-, andPP-cells, secretingglucagon, insulin, somatostatin,
and pancreatic polypeptide (PP), respectively [36, 45]. The β-
cells aremost abundant and constitute 60–80% of the endocrine
cells in islets frommice and ~50% in human islets.α-cellsmake
up ~20% inmouse and ~40% inman, while δ- and PP-cells are
more scarce constituting <10 and <1 % of the islet cells, respec-
tively. There is also a small fraction of ε-cells secreting ghrelin
[54]. Insulin decreases bloodglucose levels and insufficient insu-
linreleasefromtheβ-cellscausesmost formsofdiabetesmellitus.
Glucagon, on the contrary, increases blood glucose. Diabetic pa-
tients often showexaggeratedglucagonsecretion that contributes
to hyperglycemia, but also a reduced glucagon response to hypo-
glycemia, whichmay become fatal due to the brain’s strong glu-
cosedependence[14,50].Allmajor islethormonesarereleasedin
a pulsatile manner [15, 21, 24], which promotes hormone sensi-
tivity in the target cells [37, 42]. Indeed, insulin and glucagon
pulsatility is typically disturbed in early stages of diabetes [27,
34, 40] but themolecular mechanisms that underlie the dysregu-
lated secretion are unclear. The physiological relevance of islet
somatostatin and PP is not well understood. PP was recently
found to suppress glucagon secretion by direct effects onα-cells
[2] and somatostatin inhibits both insulin and glucagon secretion
[18]. Somatostatin pulsatility is in phase with that of insulin [20,
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21], and somatostatin’s stronger inhibitory effect on glucagon
than on insulin secretion [43] may help to shape pulsatile gluca-
gon secretion in opposite phase [29].
Studies of cell functions and interactions in situ within
pancreatic islets depend on unambiguous cell identification,
which is far from trivial. Immunostaining of dispersed islet
cells has successfully been used to identify all major islet cell
types after studying their physiological Ca2+ responses [6, 19,
30, 31], but the process is time-consuming and cells may be
lost during fixation and staining. The immunostaining ap-
proach is even more difficult when applied to cells within
pancreatic islets, since it requires that the cells remain in exact
position within the high magnification view field throughout
the identification procedure. Electrophysiological techniques
have also been used to identify α-, β-, and δ-cells [3, 8, 26]
but this approach is difficult to apply to more than one cell at a
time. The difference in expression of adrenergic receptors can
also be utilized to discriminate α- and β-cells. α-cells mainly
express α1- and β-receptors [44], which trigger elevations of
the cytoplasmic Ca2+ and cAMP concentrations in response to
adrenaline [49, 52]. In contrast, β-cells express mainly α2-
receptors [44], and adrenaline therefore lowers cAMP [49]
and suppresses Ca2+ signaling [52]. Similarly, the Ca2+ re-
sponse to glutamate has been used for identifying α- and β-
cells [9, 29] based on different expression of ionotropic glu-
tamate receptors of AMPA/kainate type. These pharmacolog-
ical tools depend on recordings of intracellular Ca2+ and
cAMP. Moreover, they do not allow unambiguous separation
of α- and β-cells from the less common δ- and PP-cells.
Cell identification by genetic labeling is an attractive alter-
native, where tissue-specific promoters are used to control
expression of fluorescent markers. This approach has been
applied to generate transgenic mice with selective expression
of fluorescent proteins in α-, β-, and δ-cells under the pro-
moters for preproglucagon, insulin, and somatostatin, respec-
tively [1, 17, 38]. A drawback with this approach is that it is
restricted to cell identification in specific transgenic mouse
strains and not practically applicable to other species.
In the present study, we tested cell-type-specific promoter-
driven expression of fluorescent proteins for identification of
mouse and human islet cells in live-cell fluorescence micros-
copy applications. To ascertain sufficient expression levels,
we constructed adenoviral vectors based on the Tet-On 3G
conditional expression system [56, 32]. The preproglucagon
promoter (Pppg), the rat insulin 2 promoter (Rip2), the so-
matostatin promoter (Psst), and the pancreatic polypeptide
promoter (Pppy) were used to drive expression of the reverse
tetracycline transactivator protein (rtTA), while the genes for
the fluorescent proteins mCherry or enhanced green fluores-
cent protein (GFP) were placed downstream of the tetracy-
cline response element. We demonstrate that this method re-
sults in mCherry or GFP expression in β-, α-, δ-, or PP-cells
with a high degree of specificity and that appropriately labeled
cells in mouse and human islets were amenable for on-line
recordings of the sub-plasma membrane Ca2+ and cAMP con-
centrations ([Ca2+]pm and [cAMP]pm).
Materials and methods
Isolation of cell-type-specific promoters
cDNA for Rip2 was a kind gift from Dr. Lena Stenson-Holst,
Lund University. Pppg, Psst, and Pppy were isolated from
genomic DNA using PCR. DNA was purified from MIN6
β-cells with PureLink® Genomic DNA Mini Kit (Thermo-
Fisher Scientific, Waltham, MA, USA) and used as PCR tem-
plate. Primer design was based on published promoter se-
quence data [11, 55, 22, 33, 25, 46, 47]. An XhoI restriction
site (underlined) was added to the sense primer (5′-ATCG
TACTCGAGGACACTCGCAATCATAAAGAGCAATC-3′
for Pppg; 5′-TATACTCGAGCAACCACTCCAAGTGGAG-
3′ for Rip2; 5′-ATATATCTCGAGAGCCTAGAGGCAGA
GCAAGCGCTG-3 ′ for Psst ; 5 ′-CATGAGGCTCG
AGTCGGAACTAGCCACTGGTTTTG-3′ for Pppy) and an
AscI site to the antisense primer (5′-AAATGGCGCGCC
TGAGCTGCGAACAGGTGTAG-3′ for Pppg; 5′-ATTT
AAATGGCGCGCCTTACTGAATCCCCAC-3′ for Rip2;
5 ′ -AATTAAGGCGCGCCGGAGACCGTGGAGA
GCTCCATAGCG-3′ for Psst; 5′-GACATATGGCGCGCC
TGTGCTGAGCTAGTGAGTG-3′ for Pppy). Standard PCR
reactions were performed with PfuTurbo high-fidelity DNA
polymerase (Agilent Technoliges, Santa Clara, CA, USA).
The 1659-bp Pppg, 684-bp Rip2, 1986-bp Psst, and 1420-bp
Pppy PCR products were purified by gel extraction, ligated
into the pCR®II-TOPO vector (Thermo-Fisher Scientific,
Waltham, MA, USA) and verified by sequencing (Eurofins
Genomics, Ebergberg, Germany). Pppg, Rip2, Psst, and
Pppy were subsequently released by digestion with XhoI
and AscI.
Construction of Tet-On 3G plasmids
with cell-type-specific promoters
To avoid the potential problem that the promoters are too
weak to drive expression of sufficient amounts of fluorescent
protein for cell identification, we took advantage of the Tet-On
conditional expression system. In this approach, a cell-type-
specific promoter could drive expression of a small amount of
rtTA, which is sufficient to strongly activate the tetracycline
response element (TRE) and downstream genes in the pres-
ence of doxycycline.
To insert the cell-type-specific promoters in plasmids
encoding rtTA, the pBR322-E3-Tet-On-rev plasmid [4] (kind
gift from Prof Göran Akusjärvi, Uppsala University) was
cleaved with XhoI and XbaI to release the cytomegalovirus
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promoter with a 5′UTR extension of the rtTA gene. This
CMV-5′UTR fragment was subsequently ligated into an in-
house made cloning vector denoted pCFH to get pCFH-CMV-
5′UTR. After cleavage with XhoI and Eco53kI, the CMV
promoter was released and replaced by the Rip2 promoter
carrying a AscI site at the 3′ end. Eventually, the Rip2-5′
UTR fragment was cut out with XhoI and XbaI and ligated
into the cleaved pBR322-E3-rtTA-ΔCMV fragment to get
pBR322-E3-Rip2-rtTA, which now included the cell-type-
specific promoter instead of the original CMV promoter. All
other promoter constructs were completed by replacing Rip2
with Pppg, Psst, or Pppy, respectively, after XhoI-AscI double
digestion. Finally, rtTA was replaced with Tet-On 3G
transactivator [32, 56] by isolating the Tet-On 3G from
pCMV-Tet3G plasmid (Clontech, USA) after digestion with
XhaI and HpaI.
Construction of plasmids for TRE-regulated mCherry
and EGFP expression
In the next step, the pTRE3G-IRES plasmid (Clontech, Palo
Alto, CA, USA) was cleaved with BglII and BamHI, to re-
lease the IRES component and insert either of the fluorescent
proteins mCherry or GFP.
Virus recombination and amplification
The four Tet-On 3G plasmids with cell-type-specific pro-
moters and the two TRE plasmids with fluorescent protein
were sent to Vector Biolabs (Philadelphia, PA, USA) for re-
combination and initial virus production. The final vector con-
structions are shown in Fig. 1. High titer virus stocks were
created in-house in HEK 293 cells grown in 15 cm Petri dishes
to about 50 % confluence. The cells were washed once with
DMEM containing 2 % (v/v) fetal bovine serum (FBS) and
infected with a titer of 2–5 MOI (multiplicity of infection)
virus in this medium for 1 h. The infection mixture was sub-
sequently removed and the cells were cultured in fresh
DMEM containing 10 % (v/v) FBS for 2 or 3 days at 37 °C
in a humidified atmosphere with 5 % CO2. When about 40 %
of the cells had started to detach from the bottom of the Petri
dish, all cells were harvested with a cell scraper, centrifuged
for 7 min at 1800g and resuspended in 2 ml 0.1 M Tris-HCl,
pH 8.0. Sodium deoxycholate (200 μl, 5 % w/v) was added
and the cells were incubated on ice for 30 min. The virus was
then released from the cells by sonication on ice three times
for 10 s with 1-min intervals. The sonication solution was
mixed with Tris-HCl and saturated CsCl and added to a
12.6-ml Quickseal tube (Beckman Instruments, Fullerton,
CA, USA) and centrifuged for 16–20 h at 115,000g, 4 °C,
with a Beckman 80Ti rotor. After centrifugation, the virus
band was sucked out with a syringe and dialyzed for 4 h at
4 °C in phosphate buffered saline supplemented with 0.9 mM
CaCl2 and 0.5 mMMgCl2 as well as 10% (v/v) glycerol. After
dialysis, the virus suspension was aliquoted and stored at
−80 °C.
Islet isolation, culture, and transduction
All procedures for animal handling and islet isolation were
approved by the Uppsala animal ethics committee. Islets of
Langerhans were isolated from C57B16J female mice as de-
scribed previously [53]. After isolation, the islets were cul-
tured for 1 to 2 days in RPMI-1640 medium containing
5.5 mM glucose, 10 % (v/v) fetal calf serum, 100 U/mL pen-
icillin, and 100 μg/mL streptomycin at 37 °C in a 5 % CO2
humidified air atmosphere. Human islets were obtained from
four normoglycemic cadaveric organ donors (two males, two
females aged 57–65 years) via the Nordic Network for
Clinical Islet Transplantation in Uppsala. All experiments
with human islets were approved by the Uppsala human ethics
committee. The isolated islets were cultured up to 7 days at
37 °C in an atmosphere of 5 % CO2 in CMRL 1066 culture
medium containing 5.5 mM glucose, 100 U/mL penicillin and
100 μg/mL streptomycin, 2 mM glutamine, and 10 % FBS.
For some experiments, the islets were dispersed into single
cells and small clusters by transferring them to 2 mL cell
dissociation buffer (Thermo Fisher Scientific) containing
10 % (v/v) trypsin-EDTA (0.05 %, Life Technologies),
a
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Fig. 1 Adenoviral gene constructs for conditional, islet cell-type-specific
expression of fluorescent proteins. The indicated fragments of the rat
insulin 2 promoter (rip2), preproglucagon promoter (ppg), somatostatin
promoter (sst), and the pancreatic polypeptide promoter (ppy) were
inserted upstream of a Tet-On 3G element expressing the reverse
tetracycline transactivator. In the presence of doxycycline, this gene
product activates the tetracycline response element (TRE3G) and the
associated promoter that drives expression of the fluorescent proteins
mCherry or green fluorescent protein (GFP)
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followed by pipetting up and down 20–30 times until all islets
were disintegrated. The trypsin digestion was interrupted by
addition of 8 ml serum-containing RPMI-1640 medium,
followed by centrifugation for 5 min at 160g and resuspension
of the cells in islet culture medium. The cell suspension was
subsequently added onto poly-lysine-coated 25-mm cover-
slips and cultured overnight. The islets or cells were infected
with adenovirus by 3 to 4 h exposure to a concentration of 105
fluorescence forming units (FFU)/islet [49], followed by ad-
dition of regular medium with 4 μM doxycycline and further
culture for 16 to 20 h before use.
Immunostaining
The infected islets were washed three times with PBS, fixed
with 4 % (w/v) paraformaldehyde for 10 min in room temper-
ature and permeabilized with 0.2 % (v/v) TrionX-100 for
10 min on ice. The reaction was blocked by adding PBS con-
taining 5 % FBS in room temperature. After 30 min incuba-
tion, the primary antibody (polyclonal rabbit anti-insulin or
polyclonal rabbit anti-glucagon from Invitrogen, Carlsbad,
CA; polyclonal rabbit anti-somatostatin from Dako,
Stockholm, Sweden; polyclonal goat anti-pancreatic polypep-
tide from Bio-Techne, Abingdon, UK) was added (1:200) for
2 h, followed by thorough rinsing with PBS. The secondary
antibody, Alexa Fluor® 488 goat anti-rabbit IgG (Invitrogen,
Carlsbad, CA) or Alexa Fluor® 488-AffiniPure F(ab’)2 frac-
tion donkey anti-goat IgG (H + L) (Jackson ImmunoResearch
Europe Ltd., Suffolk, UK), was then applied (1:200) for 1 h in
darkness. After rinsing with PBS, the islets or cells were used
for confocal microscopy imaging.
Confocal microscopy
Imaging of [cAMP]pm and [Ca
2+]pm
For imaging of [cAMP]pm, the islets were transduced with a
cyan and yellow fluorescent protein (CFP and YFP)-based
cAMP translocation biosensor [13] together with the fluores-
cent labeling vector and cultured over night. The islets or cells
were then pre-incubated for 30 min at 37 °C in experimental
buffer containing 125 mM NaCl, 4.8 mM KCl, 1.3 mM
CaCl2, 1.2 mMMgCl2, and 25 mMHEPES (pH 7.40 set with
NaOH) prior to imaging. For [Ca2+]pm recordings, the islets
were loaded with 1.3 μM of the Ca2+ indicator Fluo-4 during
the pre-incubation period. After incubation, the islets were
attached to poly-lysine-coated 25-mm coverslips and the cov-
erslips with cells or islets were mounted in an open 50-μl
chamber and superfused with experimental buffer at a rate of
0.3 ml/min. The chamber was attached to the stage of an
objective-based total internal reflection fluorescence (TIRF)
microscopy system consisting of an Eclipse Ti microscope
(Nikon) with a 60×, 1.45-NA objective and a TIRF illumina-
tor (Nikon) [49]. The chamber and superfusion medium was
thermostated to 37 °C. The 457, 491, 515, and 561 nm lines of
diode-pumped solid-state lasers (Cobolt) were used to excite
CFP, Fluo-4, YFP, and mCherry, respectively. Fluorescence
was detected with a back-illuminated EMCCD camera (DU-
897, Andor Technology) controlled by MetaFluor. Emission
wavelengths were selected with filters [485 nm/25 nm half-
bandwidth for CFP, 527/27 nm for Fluo-4, 560/40 nm for YFP
(Semrock Rochester, NY) and 620 nm long-pass for mCherry
(Melles Griot, Didam, The Netherlands)] mounted in a filter
wheel (Sutter Instruments). For time-lapse recordings, images
or image pairs were acquired every 5 s with a shutter (Sutter
Instruments) blocking the light between image captures.
Image analysis was performed with MetaFluor. Ca2+ indicator
fluorescence intensities under the plasma membrane were
expressed as changes in relation to initial fluorescence inten-
sity F0 after subtraction of background (F/F0). [cAMP]pm was
expressed as the ratio of CFP over YFP fluorescence after
subtraction of background.
Statistical analysis
Chi-square analysis with Yates correction was used to com-
pare the proportion of cells that immunostained for a hormone
in relation those with hormone promoter-controlled fluores-
cent protein expression.
Results and discussion
Fluorescence labeling of β-cells in mouse and human
pancreatic islets
Isolated mouse islets were transduced with adenovirus ex-
pressing GFP or the red fluorescent protein mCherry condi-
tionally controlled by the Rip2 promoter and the Tet-On 3G
system and subsequently imaged with confocal microscopy.
Fluorescence was absent in islets that had not been exposed to
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The islets or cells were imaged in a spinning-disk confocal
system (Yokogawa CSU-10, Andor Technology, Belfast,
Northern Ireland) attached to an Eclipse TE2000 microscope
(Nikon, Kawasaki, Japan) equipped with a 60×, 1.40-NA ob-
jective (Nikon, Kawasaki, Japan). Diode-pumped solid-state
lasers (Cobolt, Stockholm, Sweden) were used for excitation
of mCherry (561 nm) and GFP or Alexa Fluor® 488 (491 nm).
Fluorescence was selected with interference filters (520 with
35 nm half-bandwidth for GFP and Alexa Fluor® 488, and
586/20 nm for mCherry) and images were acquired with a
back-illuminated EMCCD camera (DU888, Andor
Technology) under MetaFluor software control (Molecular
Devices Corp., Downington, PA). The confocal imaging ex-
periments were performed at room temperature.
doxycycline (not shown), indicating that there is minimal leak
expression with this conditional vector system. Islets treated
overnight with 4 μM doxycycline showed bright GFP (not
shown) or mCherry fluorescence (Fig. 2a). The specificity of
the targeting strategy was evaluated using the mCherry-
expressing vectors. Transduced islets immunostained for in-
sulin showed cells with red (mCherry) and green (insulin)
fluorescence (Fig. 2a). As indicated by the Venn plot, 97 %
of the fluorescent cells stained for insulin, 28%were mCherry
positive and 26 % displayed both labels. When islets with
induced Rip2-mCherry expression were instead immuno-
stained for glucagon only 6 % of the fluorescent cells showed
both labels (Fig. 2b). mCherry expression is apparently a good
predictor of β-cell identity since 90 % of the red cells stained
for insulin and only 7 % for glucagon. When Rip2-mCherry
expression was induced in dispersed islet cells that were then
immunostained for insulin, 32 fluorescent cells all stained for
insulin and 78 % (25 cells) were also mCherry positive (not
shown). The much higher proportion of mCherry label in dis-
persed fluorescent cells as compared to those within islets (78
vs 28 %; P < 0.001) is probably due to restricted virus access
to the islet interior where most β-cells are located [45]. The
reason for the expression of Rip2-mCherry in a small
number of glucagon-positive islet cells and why no such
mistargeting was found in dispersed cells is unclear.
Human β-cells in intact islets could be identified by
the same approach, since 95 % of mCherry expressing
cells also stained for insulin (Fig. 2c), and the corre-
sponding fraction was 93 % among dispersed human
islet cells (28 of 30 cells, not shown).
Fluorescence labeling of α-cells in mouse and human
pancreatic islets
Mouse islets transduced with adenovirus containing Pppg and
mCherry or GFP showed bright red or green fluorescent cells.
As with Rip2, evaluation of targeting specificity was made
with the mCherry-expressing virus. In transducedmouse islets
immunostained for glucagon, 52 % of the fluorescent cells
were mCherry positive (Fig. 3a). This proportion is higher
than for the β-cells (28 %, P < 0.001), probably because α-
cells are more easily transduced with virus in being located in
the periphery of rodent islets [45]. mCherry expression was a
good predictor of α-cell phenotype since 73 % of the cells
within rodent islets also stained for glucagon, and the corre-
sponding fraction was 100 % among dispersed islet cells (all
of 64 cells, not shown). After instead staining for insulin 15 %
of the mCherry expressing cells within islets were positive
(Fig. 3b). This mismatch was higher than for β-cells (7 %,
P < 0.05) and it is unclear whether it reflects incomplete spec-
ificity of the relatively short Pppg sequence and/or a small
population of cells with ambiguous identity. It has been in-
creasingly recognized that islet cells show plasticity with
transdifferentiation between α- and β-cells under certain con-
ditions [48, 51, 7]. The Pppg adenovirus readily transduced
human islets and following glucagon immunostaining, 41 %
of all fluorescent cells were mCherry positive. This proportion
tended to be lower than in mouse islets (52 %, P = 0.068),
which is expected since human α-cells are not preferentially
located in the islet periphery [45]. Among the mCherry-













Fig. 2 Insulin promoter-
controlled expression of mCherry
in mouse and human islet cells.
Confocal microscopy images of
Rip2-controlled mCherry
expression and insulin or
glucagon immunostaining in
mouse and human islets. a Rip2-
mCherry expressing and insulin
positive cells in a mouse islet. b
Rip2-mCherry expressing and
glucagon positive cells in a mouse
islet. c Rip2-mCherry expressing
and insulin positive cells in a
human islet. Scale bars, 10 μm.
The Venn diagrams on the right
show the total number of cells
with hormone staining (green),
mCherry expression (red), and
both (yellow)
Pflugers Arch - Eur J Physiol (2016) 468:1765–1777 1769
by glucagon immunostaining (Fig. 3c), and the corresponding
fraction was 85 % for dispersed human islet cells (47 of 55
cells, not shown).
Fluorescence labeling ofmouse and humanδ- and PP-cells
The adenovirus with Psst and Pppy transduced relatively few
cells inmouse and human islets. To effectively find these cells,
we transduced and immunostained dispersed mouse and hu-
man islet cells. The Psst-mCherry expression overlapped with
positive anti-somatostatin staining in 86–87% in both species,
verifying their identity as δ-cells (Fig. 4a, b). Labeling with
Pppy-mCherry was observed both in mouse (Fig. 4c) and
human (Fig. 4d) PP-cells, whose identity was verified by pos-
itive PP-immunostaining in 88 % of the mouse and 93 % of
the human cells.
TIRF recordings of [Ca2+]pm in islet cells identified
by cell-type-specific fluorescent protein expression
We next testedwhether the cell identification strategy could be
used in live-cell imaging applications. Islets transduced with
the respective cell-type-specific vector expressing mCherry
were loaded with the green fluorescent Ca2+ indicator fluo-4,
which does not show spectral overlap with the red label. The
islets were imaged with a total internal reflection fluorescence
microscope, which excites a small volume within <100 nm of
the plasma membrane of the cells in contact with the
coverslip. Although this technique does not enable analysis
of cells located deeper in the islet, it is advantageous in
allowing recordings from small cells with weak fluorescence
without contamination from cells located in a different focal
plane.
We stimulated the islets with various concentrations of glu-
cose and tested the responses to the KATP channel opener
diazoxide and the neurotransmitters glutamate and adrenaline,
which have been used to discriminate between the different
islet cell types [9, 29, 49, 52]. Mouse β-cells identified by
their Rip2-controlled mCherry fluorescence showed low and
stable [Ca2+]pm in the presence of 3 mM glucose (Fig. 5a).
Increase of the glucose concentration to 7 mM resulted in
lowering of [Ca2+]pm, known to reflect stimulated uptake of
Ca2+ into the endoplasmic reticulum, followed after a few
minutes delay by an increase reflecting voltage-dependent
Ca2+ influx [10]. Further elevation of glucose to 11 mM re-
sulted again in transient lowering followed by rise of [Ca2+]pm
with typical slow oscillations that underlie pulsatile insulin
secretion. Application of the hyperpolarizing agent diazoxide
(250 μM) interrupted the voltage-dependent Ca2+ influx and
[Ca2+]pm levels returned to baseline. Under these conditions,
the β-cells did not respond to 1 mM glutamate or 10 μM
adrenaline (Fig. 5a). The observed response pattern is charac-
teristic of β-cells and there was not much variability between
different cells. From these observations, we conclude that the














Fig. 3 Glucagon promoter-
controlled expression of mCherry
in mouse and human islet cells.
Confocal microscopy images of
Pppg-controlled mCherry
expression and insulin or
glucagon immunostaining in
mouse and human islet cells. a
Pppg-mCherry expressing and
glucagon positive cells in a mouse
islet. b Pppg-mCherry expressing
and insulin positive cells in a
mouse islet. c Pppg-mCherry
expressing and glucagon positive
cells in a human islet. Scale bars,
10 μm. The Venn diagrams on the
right show the total number of
cells with hormone staining
(green), mCherry expression
(red), and both (yellow)
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Variability of [Ca2+]pm responses to glucose in α-cells
Recordings from α-cells identified by Pppg-mCherry fluores-
cence were largely consistent with a previous study of α-cell
[Ca2+]pm signaling [29]. Accordingly, most cells showed ir-
regular brief [Ca2+]pm oscillations in the presence of 3 mM
glucose, and increases of the glucose concentration to 7 and
11 mM did not induce sustained suppression of [Ca2+]pm sig-
naling (Fig. 5b) but there was sometimes a transient interrup-
tion of [Ca2+]pm oscillations or somewhat lower amplitude of
the oscillations at 11 mM compared to 3 mM glucose. Seven
out of 10α-cells showed no or weak response to KATP channel
activation with diazoxide (Fig. 5b), supporting the view that
this channel may not be required for glucose regulation of
glucagon secretion [14]. In accordance with previous obser-
vations [29], the mouse α-cells responded to 1 mM glutamate
with a distinct, stable [Ca2+]pm elevation (Fig. 5b). Also,
10 μM adrenaline induced [Ca2+]pm elevation but this re-
sponse was usually weaker and/or more transient than that to
glutamate. mCherry-negative cells from the same islets
showed β-cell-like responses with low and stable [Ca2+]pm
at 3 mM glucose, a distinct increase of [Ca2+]pm at 11 mM,
which was reversed by diazoxide, and no responses to
glutamate or adrenaline (Fig. 5b). Our genetic labeling strate-
gy thus mostly identifies α- and β-cells with characteristic
[Ca2+]pm responses to low and high glucose concentrations
as well as to glutamate and adrenaline.
A few mCherry-positive α-cells showed somewhat more β-
cell-like response with absence of prominent [Ca2+]pm signaling
activity at 3 mM glucose and distinct [Ca2+]pm increases after
elevation of glucose to 7 mM (Fig. 5c). The two types of α-cell
responses were sometimes observed in different cells within the
same islet. In the cell shown in Fig. 5c, the glucose-induced
[Ca2+]pm elevation was reversed by diazoxide, like in β-cells.
One may speculate that this type of response represents
Bmislabeled^ cells with Pppg-controlled mCherry expression
andpositive immunostainingfor insulin.However, thecellshown
in Fig. 5c responded to glutamate and adrenaline like a typicalα-
cell. Simultaneous recording from an adjacentmCherry negative
cell exhibited the typical β-cell behavior with glucose-induced
[Ca2+]pm increases and lack of glutamate and adrenaline re-
sponses. The results indicate possible presence of sub-
populations of α-cells that respond differently to glucose.
Although glucose is generally an inhibitor of glucagon release,
secretion frompurified rodentα-cells is paradoxically stimulated





















Fig. 4 Somatostatin and PP
promoter-controlled expression of
mCherry in mouse and human
islet cells. Confocal microscopy
images of Psst- and Pppy-
controlled mCherry expression
and somatostatin and PP
immunostaining in dispersed
mouse and human islet cells. a, b
Psst-mCherry expressing and
somatostatin positive mouse (a)
and human (b) islet cells. c, d
Pppy-mCherry expressing and PP
positive mouse (c) and human (d)
islet cells. Scale bars, 10 μm. The
Venn diagrams on the right show
the total number of cells with
hormone staining (green),
mCherry expression (red), and
both (yellow)
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FACS sorting somehow selects for the α-cells with β-cell-like
Ca2+ responses and glucose-stimulated glucagon secretion, al-
though the α-cells with glucose-inhibited secretion dominate
within the islet. However, there is also evidence that Ca2+ signal-
ingmaydifferbetweenisolatedα-cellsandthosewithinislets [29,
53] and that glucagon release is controlled by factors that may
override a stimulatory [Ca2+]pm signal [28, 29]. It is pertinent to
note that the dose-response relationship for glucose-regulated
glucagon secretion is U-shaped with maximal inhibition at
7 mM glucose. At higher concentrations of the sugar, inhibition
is gradually diminished and secretion even stimulated [28, 41]. It
remains to establish if the population of α-cells with
[Ca2+]pm increase in response to glucose elevation may
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Fig. 5 Recordings of sub-plasma membrane Ca2+ concentration in β-
and α-cells identified by cell-type-specific promoter-controlled
expression of mCherry. TIRF microscopy recordings of [Ca2+]pm in
cells within intact mouse islets loaded with the Ca2+ indicator Fluo-4
and exposed to 3–11 mM glucose, 250 μM diazoxide (Diaz), 1 mM
glutamate (Glu), and 10 μM adrenaline (Adr). a [Ca2+]pm recording
from a β-cell identified by Rip2-mCherry expression. Increase of the
glucose concentration from 3 to 7 mM induces elevation of [Ca2+]pm,
which is reversed by diazoxide. Glutamate and adrenaline are without
effect on basal [Ca2+]pm. Representative of 18 cells from five islets. b
[Ca2+]pm recording from an α-cell identified by Pppg-mCherry
expression and an adjacent β-cell identified by the cell-type-specific
[Ca2+]pm response pattern. Irrespective of the glucose concentration, the
α-cell shows irregular [Ca2+]pm oscillations which are not interrupted by
diazoxide. Glutamate and adrenaline increases [Ca2+]pm in theα-cell. The
β-cell shows typical [Ca2+]pm elevation in response to 11 mM glucose.
Representative of 7 out of 10 α-cells in five islets. c [Ca2+]pm recording
from another α-cell identified by Pppg-mCherry expression and an
adjacent β-cell identified on the typical response pattern. The α-cell
shows β-cell-like responses with glucose-induced elevation of [Ca2+]pm
that was reversed by diazoxide. However, in contrast to the β-cell, the α-
cell readily responds to glutamate and adrenaline. Representative for 3 out
of 10 α-cells in five islets. Scale bars, 10 μm
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conclude that our labeling approach dominatingly selects
for α-cells with expected [Ca2+]pm responses to glutamate
and adrenaline and reveals a considerable variability in the
α-cell reactivity to glucose.
[Ca2+]pm signaling in mouse δ-cells
[Ca2+]pm recordings in islet cells identified as δ-cells by Psst-
controlled mCherry expression showed fast and irregular
[Ca2+]pm oscillations in the presence of 3 mM glucose, thus
reminiscent of the responses in α-cells (Fig. 6a). The pattern
was not clearly changed by elevating glucose to 7 or 11 mM.
Diazoxide reduced [Ca2+]pm, consistent with the involvement
of KATP channels in δ-cell electrical activity [5, 8, 16].
Glutamate induced prompt [Ca2+]pm elevation in δ-cells but
there was no clear effect of adrenaline. In addition to the ge-
netically labeled δ-cell, Fig. 6a shows [Ca2+]pm recordings
from two unlabeled cells, which based on the [Ca2+]pm signal-
ing patterns probably are α- and β-cells.
Another example of δ-cell [Ca2+]pm signaling is shown in
Fig. 6b. Apart from the mCherry-expressing δ-cell, the record-
ing includes a non-expressingβ-cell. When the glucose concen-
tration was increased from 3 to 20 mM, the β-cell shows the
typical transition from silence at low glucose to [Ca2+]pm eleva-
tion followed by quite regular, slow oscillations and [Ca2+]pm
reaches baseline within 10 min after restoration of glucose to
3 mM. In contrast, the δ-cell is active at 3 mM glucose with no
major change after introduction of 20 mM glucose. After
3 mM 7 mM 11 mM glucose




































































Fig. 6 Recordings of [Ca2+]pm in
islet cells identified by cell-type-
specific promoter-controlled
expression of mCherry. TIRF
microscopy recordings of
[Ca2+]pm in cells within intact
mouse islets loadedwith Fluo-4. a
[Ca2+]pm recording from a δ-cell
identified by Psst-mCherry
expression and adjacentα- andβ-
cells identified by typical
response patterns. The δ-cell
shows irregular [Ca2+]pm
elevations already at low glucose
concentrations and diazoxide
lowers [Ca2+]pm, while glutamate
induces an increase.
Representative of 8 δ-cells from
six islets. b [Ca2+]pm recording
from a Psst-mCherry-identified δ-
cell and an adjacent β-cell with
typical response pattern. In the
presence of high glucose, the β-
cell shows regular [Ca2+]pm
oscillations that are synchronized
with those in the δ-cell. c
[Ca2+]pm recording in a PP-cell
identified by Pppy-mCherry
expression showing that the cell is
active already at low glucose
concentrations. Representative of
three PP-cells from three islets.
Scale bars, 10 μm
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approximately 10 min, the [Ca2+]pm oscillations in the δ-cell
become well synchronized with those in the β-cell (Fig. 6b).
The temporal relationship between [Ca2+]pm oscillations in β-
and δ-cells within intact islets have previously not been clarified,
but since pulsatile release of insulin and somatostatin is synchro-
nized in phase [21], the prediction is that [Ca2+]pm oscillations
are synchronized in the same phase. Similar synchronization
was recently found also between β- and α-cells, although insu-
lin and glucagon pulses are synchronized in opposite phase [29].
This apparent paradox may be explained by release of
somatostatin that suppresses glucagon secretion with lit-
tle influence on α-cell [Ca2+]pm.
[Ca2+]pm signaling in identified PP-cells
PP-cells identified by Pppy-mediated expression of mCherry
were also amenable for [Ca2+]pm recordings. Figure 6c shows
an example of a PP-cell exhibiting [Ca2+]pm oscillations in the
presence of 3 mM glucose, which did not change appearance
when glucose is increased to 7 or 11 mM. However, diazoxide
promptly interrupted the signaling.There isonly aweak response
to glutamate and no consistent response to adrenaline (Fig. 6c).
Imaging cells co-expressing genetically encoded biosensors
and an identity marker
We next tested whether the fluorescent protein labeling strat-
egy could be used also in cells simultaneously expressing a
genetically encoded biosensor. We transduced mouse or hu-
man islets with adenovirus for Rip2-mCherry and a CFP/
YFP-based biosensor for [cAMP]pm [12]. Figure 7a shows a
[cAMP]pm recording in two β-cells during an increase of the
glucose concentration from 3 to 20 mM. Both cells show an
initial [cAMP]pm elevation followed by a decline and a more
pronounced increased with slow oscillations that are synchro-



























































































































Fig. 7 Recordings of [cAMP]pm in islet β-cells identified by cell-type-
specific promoter-controlled expression of mCherry. TIRF microscopy
recordings of [cAMP]pm in β-cells within intact islets identified by
Rip2-mCherry expression. The images show expression of Rip2-
mCherry and the CFP- and YFP-labeled components of the cAMP
reporter. [cAMP]pm is expressed as the CFP/YFP intensity ratio with
the prestimulatory level normalized to unity (black traces). The blue
and yellow traces show the CFP and YFP fluorescence intensity raw
data. a [cAMP]pm recordings from two mouse β-cells in the same islet.
Elevation of the glucose concentration from 3 to 20 mM induces
synchronized, oscillatory increases of [cAMP]pm. Representative of 40
cells from 10 islets. b [cAMP]pm recording from a human β-cell during
elevation of the glucose concentration from 3 to 20 mM followed by
addition of 100 nM GIP, 100 nM GLP-1, and 10 μM adrenaline (Adr).
Representative of four cells from three islets from one donor. Scale bars,
10 μm
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lack direct physical contact, the synchronization may be ex-
plained by indirect coupling due to extensive gap junctions
between mostβ-cells within the islet [39]. We also transduced
human islets with the Rip2-mCherry virus. The β-cell in
Fig. 7b shows a very modest [cAMP]pm elevation in response
to 20 mM glucose but pronounced [cAMP]pm increases after
stimulation with 100 nM of the gluco-incretin hormones GIP
(glucose-dependent insulinotropic polypeptide) and GLP-1
(glucagon-like peptide 1). The recording also demonstrates
the β-cell typical reduction of [cAMP]pm after exposure to
10 μM adrenaline (Fig. 7b).
Concluding remarks
We have created a set of viral vectors that allow pancreatic
islet cell-specific expression of fluorescent proteins for their
identification in various live-cell imaging applications. These
vectors provide a valuable addition to the toolbox for live-cell
imaging applications. In such settings, fluorescent cells are
easily identified and simultaneous recordings can often be
made on several cells. We first applied the tools with
[Ca2+]pm recordings to verify that cells responded normally
to well-known stimuli and previously described functional
identification criteria. These initial measurements highlighted
a previously overlooked [Ca2+]pm response pattern in certain
α-cells and indicated that [Ca2+]pm oscillations in β-cells are
synchronized with those in δ-cells. We also demonstrated that
the labeling strategy can be combined with genetically
encoded fluorescence biosensors as exemplified by intracellu-
lar cAMP recordings. This approach is considerably more
flexible than cell-type-specific expression of biosensors. The
potential of this system could be further improved using an
infrared fluorescent protein for identification, and leave the
visual spectral channels for functional biosensors.
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